| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $813.2M | +93.4% |
| Cost of Revenue | $417.5M | +25.8% |
| Gross Profit | $395.7M | +347.6% |
| R&D Expense | $3.9M | +30.0% |
| SG&A Expense | $55.2M | +10.6% |
| Operating Income | $328.4M | +1005.7% |
| Pre-tax Income | $335.4M | +1303.3% |
| Income Tax | $61.9M | +165.7% |
| Net Income | $273.5M | — |
| EPS (Basic) | $1.59 | — |
| EPS (Diluted) | $1.36 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $189.0M | +67.3% |
| Accounts Receivable | $141.6M | +46.9% |
| Inventory | $152.3M | +13.2% |
| Current Assets | $544.0M | +36.2% |
| Total Assets | $2.07B | +72.5% |
| Current Liabilities | $148.7M | +13.3% |
| Long-term Debt | $241.9M | +0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $454.7M | +1622.3% |
| Capital Expenditures | $336.9M | +155.4% |
| Investing Cash Flow | -$364.7M | -154.5% |
| Financing Cash Flow | -$12.5M | -105.7% |
| Free Cash Flow | $117.8M | +211.7% |
| Total Liabilities |
| $631.2M |
| +55.0% |
| Stockholders' Equity | $1.44B | +81.4% |